Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Somatostatin may help protect hair follicles from immune attacks.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Red blood cell folate levels are reliable indicators of long-term folate status in alopecia areata patients.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Early treatment of mixed connective tissue disease is crucial to prevent severe autoimmune conditions.

Individualized treatment and psychological support are crucial for alopecia.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.